Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay
- 25 February 2007
- journal article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 12 (1) , 42-47
Abstract
The present study investigated whether treatment with anginex, a novel antiangiogenic peptide, could block re-vascularization after radiation treatment. A squamous cell (SCCVII) xenograft tumor mouse model was employed to assess the effects of anginex given post-radiation on tumor growth, microvessel density (MVD), and oxygen levels. The oxygen status was determined by the partial pressure of O2. Tumors in untreated mice increased threefold in 7.0 days, anginex-treated tumors (10 mg/kg intraperitoneal, twice) required 7.3 ± 0.9 days, and tumors exposed to 8-Gy radiation increased threefold over 11 days. Combination treatment of anginex and radiation caused the tumors to grow threefold in 16.1 ± 1.6 days, a delay which was significant and deemed supra-additive. Oxygen levels in tumors treated by stand-alone or combination therapies were significantly reduced; for example from 19.5 ± 4.9 mmHg in controls to 9.7 ± 1.9 mmHg in combination-treated, size-matched tumors. In addition, immunohistochemistry showed a decrease in MVD in the tumors treated with anginex, radiation, or the combination. These results suggest that a combination of anginex and radiation can greatly affect the amount of functional vasculature in tumors and prolong radiation-induced tumor regression. Antiangiogenesis therapy with anginex, in addition to radiotherapy, will be useful by blocking angiogenesis-dependent regrowth of vessels.Keywords
This publication has 24 references indexed in Scilit:
- Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesisJournal of Controlled Release, 2005
- Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cellsInternational Journal of Cancer, 2005
- beta-Sheet is the bioactive conformation of the anti-angiogenic anginex peptideBiochemical Journal, 2003
- The designer antiangiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal modelsThe FASEB Journal, 2002
- Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vectorGene Therapy, 2002
- Anginex, a designed peptide that inhibits angiogenesisBiochemical Journal, 2001
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression.Journal of Cell Biology, 1994
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Angiogenic FactorsScience, 1987